Search Results 351-360 of 9872 for Primary biliary cholangitis
Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor. Biomedicines. 2025 Sep 24 ...
Primary sclerosing cholangitis, or PSC, is a condition that damages the ducts that carry digestive bile from the liver to the small intestine. Many ...
... cirrhosis of the liver. Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
... primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), the latter of which has no medical cure. In 2011, he joined the Mayo Clinic ...
Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows ...
, Primary biliary cholangitis, Primary sclerosing cholangitis, Portal hypertension, Autoimmune hepatitis, Hemochromatosis, Alcoholic hepatitis, Biliary atresia.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.